Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 42Small Cell Lung Carcinoma 19Breast Neoplasms 16Sarcoma 12Lung Neoplasms 9Esophageal Squamous Cell Carcinoma 7Carcinoma, Hepatocellular 7Thyroid Neoplasms 6Stomach Neoplasms 6Nasopharyngeal Carcinoma 6Esophageal Neoplasms 6Ovarian Neoplasms 5NSCLC 5Carcinoma 5Triple Negative Breast Neoplasms 4Pheochromocytoma 4Pancreatic Neoplasms 4Neoplasm Metastasis 4Colorectal Neoplasms 4Carcinoma, Ovarian Epithelial 4Recurrence 3Paraganglioma 3Neoplasms 3Glioma 3Cholangiocarcinoma 3Brain Neoplasms 3Biliary Tract Neoplasms 3Uterine Cervical Neoplasms 2Urogenital Neoplasms 2Platinum-resistant Ovarian Cancer 2

Interventions

Diathermy 20Radiotherapy 11Fluorouracil 4Drug Therapy 4Cisplatin 4Radiation 3Immune Checkpoint Inhibitors 3Brachytherapy 3tislelizumab 2Surgical Procedures, Operative 2Solutions 2Immunotherapy 2Hyperthermia, Induced 2Hydrogen Peroxide 2Conization 2Capecitabine 2spartalizumab 1anlotinib 1Temozolomide 1Saline Solution 1Radiation Dose Hypofractionation 1Patient Reported Outcome Measures 1Paclitaxel 1Oxaliplatin 1Mitomycin 1Ifosfamide 1Hyperthermic Intraperitoneal Chemotherapy 1Gemcitabine 1Folfox protocol 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hyperthermia × anlotinib × Clear all
NCT06249750 2024-02-08

Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer

Zhejiang Hospital

Phase 2 Recruiting
60 enrolled

Hyperthermia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡